menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Researchers Support New Strategies for HIV Control

Researchers Support New Strategies for HIV Control
12/20/2019
news.ki.se

News.ki.se

AIDS is a persistent global health issue with no existing vaccine or cure. HIV infection typically leads to a loss of CD4+ T cells, a type of white blood cells that together with the CD8+ T cells attack and destroy infections. The less CD4+ T cells a person has, the worse are the symptoms. But fewer than 1 percent of HIV-positive people have stable CD4+ T cell counts and undetectable HIV viremia and are thus able to live with the virus without therapy. This group, known as elite controllers, has more effective CD8+ T cells—the cells that kill off viruses—than most HIV-positive people.

In this study, published in Science Translational Medicine, the researchers wanted to find out exactly how the CD8+ T cells of elite controllers keep the HIV virus from replicating and progressing to AIDS. They collected blood samples and lymph node tissue biopsies of a total of 51 HIV-positive individuals, including 12 elite controllers, from three different sites in the U.S. and Mexico.

Elite Controllers Had More CD8+ T Cells

Using single-cell RNA sequencing analyses, a method used to study individual cells, the researchers found that elite controllers had more HIV-specific CD8+ T cells in their lymphoid tissue than the others but that these were so-called non-cytolytic cells, meaning they didn’t kill off infected cells. Instead these CD8+ T cells of elite controllers had a distinct transcriptional profile and were able to suppress HIV replication through an enhanced ribosomal function, meaning they were better at translating proteins from amino acids. This led to the production of more and a greater variety of cytokines, small protein molecules that are important in cell communication, and boosted the cells’ polyfunctionality.

“These findings go against the paradigm of HIV control that focuses on killing off infected cells to find a cure,” says Marcus Buggert, assistant professor at the Department of Medicine, Huddinge, at Karolinska Institutet. “While these strategies may still work, our research supports a model in which viral suppression rather than viral eradication can in fact serve as a functional cure.”

Facebook Comments

Programs 5/17/21